Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Aurora Cannabis Inc
Nieuws
Aurora Cannabis Inc
ACB
NAS
: ACB
| ISIN: CA05156X8843
19:02
7,390 USD
(-2,89%)
(-2,89%)
19:02
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Technische analyse
TA
Toon enkel gratis nieuws
15 mei 2024 ·
Aurora Cannabis Announces Appointment of New Director
· Persbericht
8 mei 2024 ·
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
· Persbericht
30 april 2024 ·
Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products
· Persbericht
1 april 2024 ·
Aurora Cannabis Commends Germany's Landmark Legalization Achievement
· Persbericht
20 maart 2024 ·
Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance
· Persbericht
4 maart 2024 ·
Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia
· Persbericht
29 februari 2024 ·
Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]
· Persbericht
28 februari 2024 ·
Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis
· Persbericht
20 februari 2024 ·
Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation
· Persbericht
8 februari 2024 ·
Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
· Persbericht
8 februari 2024 ·
Aurora Cannabis Acquires MedReleaf Australia
· Persbericht
31 januari 2024 ·
Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call
· Persbericht
24 januari 2024 ·
Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch
· Persbericht
9 november 2023 ·
Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA
· Persbericht
26 oktober 2023 ·
Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call
· Persbericht
24 oktober 2023 ·
Aurora Cannabis Announces Settlement of Patent Litigation
· Persbericht
3 oktober 2023 ·
Aurora Cannabis Inc. Announces Closing of its C$38.8 Million Bought Deal Financing, Including the Full Exercise of the Over-Allotment Option
· Persbericht
19 september 2023 ·
Aurora Launches Bold New Brand Tasty's into Canadian Adult Market
· Persbericht
19 september 2023 ·
Aurora Confirms Approval of Transfer to Nasdaq Capital Market; Enters into Agreement to Repurchase a Further ~ US$9.6 Million Principal Amount of Convertible Notes
· Persbericht
8 september 2023 ·
Aurora Repurchases ~US$9.0 Million Principal Amount of Convertible Notes; Continues Progress Towards Positive Free Cash Flow with less than ~US$39 Million of Notes Outstanding
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe